INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) (00534147) is a long-established pri/ltd by guar/nsc (private, limited by guarantee, no share capital) based in the United Kingdom, with over 72 years of operating history since 1954. The company operates in the other research and experimental development on natural sciences and engineering sector. We currently track 18 data signals for this company from 12 sources. Risk assessment: 77/100 ("robust"), reflecting a strong compliance and financial profile. The company has 3 outstanding mortgage charges registered with Companies House. Note: the company's accounts appear to be overdue.
Institute of Cancer Research: Royal Cancer Hospital (The) (00534147) is an active private company limited by guarantee with no share capital, incorporated in 1954, focusing on research and development in natural sciences and engineering, located in the UK.
Limited public data available — fewer records than most UK companies. Risk score of 77 indicates a strong compliance profile.
INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) is 1 of 5,626 active companies in this sector nationally (6,152 including dissolved).
The 7 directors of INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) are connected to 22 other companies.
None of these connected companies have been dissolved.
INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) is listed as the proprietor of 4 properties in the HM Land Registry.
Properties are located in Greater London, South East.
INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) has received 4 Innovate UK grants. This shows active participation in UK innovation programmes.
This company profile is built from 11 official data sources: Ch Charges, Ch Officers, Charity Commission, Companies House, DWP, Environment Agency, GLEIF, Gateway to Research, HM Land Registry, ICO, Innovate UK.
Institute of Cancer Research: Royal Cancer Hospital (The) (00534147) is an active private company limited by guarantee with no share capital, incorporated in 1954, focusing on research and development in natural sciences and engineering, located in the UK..
Current directors include DAME CAROLINE ANN PALMER, PROFESSOR CLARE MARGARET ISACKE, MR KARL MUNSLOW ONG and 2 more.
INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) operates under SIC code 72190 — Other research and experimental development on natural sciences and engineering.
INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) has a risk score of 77 out of 100, classified as "Robust". This score is calculated from 18 data signals across 12 government sources.
The next accounts for INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) are due on 30 Apr 2026 — this filing is currently overdue.
Yes, INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) is listed as the proprietor of 4 properties in the HM Land Registry, located in Greater London, South East.
The dissolution rate for the other research and experimental development on natural sciences and engineering sector in the UK is 0.2%. The average company age in this sector is 10.8 years.
INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) is currently listed as "Active" on Companies House, indicating it is still a registered company. An "Active" status means the company has not been dissolved, struck off, or entered into liquidation.
INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) is registered as a PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital), which is a registered UK business entity.
INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) was incorporated on 4 Jun 1954, making it 72 years old. The company remains active and in good standing.
INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE) is classified under SIC code 72190 (Other research and experimental development on natural sciences and engineering). The Standard Industrial Classification system is used by the UK government to categorise businesses by their primary economic activity.
We track 18 data signals from 12 official government sources for INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (THE).